Rivas Goldstein, LLP Call : 646-859-3790

Two things to know about new HHS proposed rules

The United States Centers for Medicare and Medicaid Services (CMS) recently released proposals that will directly impact the health care industry. Two potential impacts to watch include changes made in response to the current coronavirus pandemic and a potential move to support an increased shift towards the use of value-based drugs.

Here are the basics.

COVID-19 related changes

If approved, the agency's proposed rule for the Home Health Prospective Payment System would go into effect in 2021. According to the agency, the proposal is designed to update the payment rates and wage index. Another change, as noted above, includes language to make certain changes regarding the use of technology to provide services permanent.

In order to qualify, the agency notes the plan of care must generally include a provision of remote patient monitoring using such technology for patient-specific needs to help achieve the overall goals of the plan of care.

Proposal could result in increase of value-based drugs

Another proposal supports flexibility to enter "innovative value-based purchasing arrangements (VBPs) with manufacturers," likely paving the way for further adoption of value-based purchasing. If approved, the change would update rules relating to Medicaid drug pricing that are over three decades old. The changes would broaden the definition of VBPs and adjust reporting requirements.

As noted in a recent discussion published in The National Law Review, the later proposal could signal an upcoming increase in VBP proposals. President Donald Trump has made it clear that he intends to lower drug prices, and the administration may see it fit to move such proposals forward before November elections.

No Comments

Leave a comment
Comment Information
Email Us For A Response

Schedule A Consultation With An Attorney

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Privacy Policy

Austin Office
3345 Bee Cave Rd, Suite 104
Austin, TX 78746

Phone: 512-481-2916
Map & Directions

New York Office
By Appointment Only
405 Lexington Ave 26th Floor
New York, NY 10174

Phone: 646-859-3790
Map & Directions

New Jersey Office
By Appointment Only
1 Gateway Center, Suite 2600
Newark, NJ 07102

Phone: 646-859-3790
Map & Directions

Review Us